Emerging studies emphasizes this benefit of blocking endothelin-BR receptor through {anti-specific antibodies. Certain antibodies present a targeted method to affect disease processes mediated by excessive ETBR signaling. Specifically, inhibiting ETBR may lessen tissue damage and aid prognosis in several disease settings, positioning {anti-specific